BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36717871)

  • 1. Bridging the gap? Local production of medicines on the national essential medicine lists of Kenya, Tanzania and Uganda.
    Baldeh AO; Millard C; Pollock AM; Brhlikova P
    J Pharm Policy Pract; 2023 Jan; 16(1):18. PubMed ID: 36717871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Registration of essential medicines in Kenya, Tanzania and Uganda: a retrospective analysis.
    Green A; Lyus R; Ocan M; Pollock AM; Brhlikova P
    J R Soc Med; 2023 Oct; 116(10):331-342. PubMed ID: 37343667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Registration of antimicrobials, Kenya, Uganda and United Republic of Tanzania, 2018.
    Lyus R; Pollock A; Ocan M; Brhlikova P
    Bull World Health Organ; 2020 Aug; 98(8):530-538. PubMed ID: 32773898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of government agencies and other actors in influencing access to medicines in three East African countries.
    Odoch WD; Dambisya Y; Peacocke E; Sandberg KI; Hembre BSH
    Health Policy Plan; 2021 Apr; 36(3):312-321. PubMed ID: 33569583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Access to essential cancer medicines for children: a comparative mixed-methods analysis of availability, price, and health-system determinants in east Africa.
    Petricca K; Kambugu J; Githang'a J; Macharia WM; Njuguna F; McLigeyo A; Nyangasi M; Orem J; Kanyamuhunga A; Laiti R; Katabalo D; Schroeder K; Rogo K; Maguire B; Wambui L; Nkurunziza JN; Wong B; Neposlan J; Kilawe L; Gupta S; Denburg AE
    Lancet Oncol; 2023 May; 24(5):563-576. PubMed ID: 37023781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list.
    Naicker I; Suleman F; Perumal-Pillay VA
    J Pharm Policy Pract; 2022 Dec; 15(1):97. PubMed ID: 36482421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Registration and local production of essential medicines in Uganda.
    Brhlikova P; Maigetter K; Murison J; Agaba AG; Tusiimire J; Pollock AM
    J Pharm Policy Pract; 2020; 13():31. PubMed ID: 32793355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Audit of essential medicine listing and registration status of medicines on standard treatment guidelines in Kenya, Tanzania and Uganda: Case study of malaria, tuberculosis, hypertension and type 2 diabetes mellitus.
    Babatunde D; Pollock AM; Ocan M; Brhlikova P
    JRSM Open; 2024 Mar; 15(3):20542704241232814. PubMed ID: 38560365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National medicines regulatory authorities financial sustainability in the East African Community.
    Ndomondo-Sigonda M; Miot J; Naidoo S; Ng'andu B; Ngum N; Masota NE; Kaale E
    PLoS One; 2020; 15(7):e0236332. PubMed ID: 32702048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The East African Community (EAC) mobile laboratory networks in Kenya, Burundi, Tanzania, Rwanda, Uganda, and South Sudan-from project implementation to outbreak response against Dengue, Ebola, COVID-19, and epidemic-prone diseases.
    Affara M; Lagu HI; Achol E; Karamagi R; Omari N; Ochido G; Kezakarayagwa E; Kabatesi F; Nkeshimana A; Roba A; Ndia MN; Abudo MU; Kabanda A; Mpabuka E; Mwikarago EI; Kutjok PE; Samson DD; Deng LL; Moremi N; Kelly ME; Mkama PBM; Magesa A; Balinandi SK; Pimundu G; Nabadda SN; Puradiredja DI; Hinzmann J; Duraffour S; Gabriel M; Ruge G; Loag W; Ayiko R; Sonoiya SS; May J; Katende MJ; Gehre F
    BMC Med; 2021 Jul; 19(1):160. PubMed ID: 34238298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Access to and Affordability of World Health Organization Essential Medicines for Cancer in Sub-Saharan Africa: Examples from Kenya, Rwanda, and Uganda.
    Kizub DA; Naik S; Abogan AA; Pain D; Sammut S; Shulman LN; Martei YM
    Oncologist; 2022 Nov; 27(11):958-970. PubMed ID: 36094141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local production of pharmaceuticals in Africa and access to essential medicines: 'urban bias' in access to imported medicines in Tanzania and its policy implications.
    Mujinja PG; Mackintosh M; Justin-Temu M; Wuyts M
    Global Health; 2014 Mar; 10():12. PubMed ID: 24612518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Assessment of the National Pharmacovigilance Systems in East Africa: Ethiopia, Kenya, Rwanda and Tanzania.
    Barry A; Olsson S; Minzi O; Bienvenu E; Makonnen E; Kamuhabwa A; Oluka M; Guantai A; Bergman U; van Puijenbroek E; Gurumurthy P; Aklillu E
    Drug Saf; 2020 Apr; 43(4):339-350. PubMed ID: 31919794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of scaling up various community-level interventions on child mortality in Burundi, Kenya, Rwanda, Uganda and Tanzania: a modeling study.
    Hategeka C; Tuyisenge G; Bayingana C; Tuyisenge L
    Glob Health Res Policy; 2019; 4():1. PubMed ID: 31168481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential medicines availability is still suboptimal in many countries: a scoping review.
    Mahmić-Kaknjo M; Jeličić-Kadić A; Utrobičić A; Chan K; Bero L; Marušić A
    J Clin Epidemiol; 2018 Jun; 98():41-52. PubMed ID: 29452222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare workers' perspectives on access to sexual and reproductive health services in the public, private and private not-for-profit sectors: insights from Kenya, Tanzania, Uganda and Zambia.
    Ooms GI; van Oirschot J; Okemo D; Reed T; van den Ham HA; Mantel-Teeuwisse AK
    BMC Health Serv Res; 2022 Jul; 22(1):873. PubMed ID: 35794551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism.
    ; Tougher S; Hanson K; Goodman C
    Malar J; 2017 Apr; 16(1):173. PubMed ID: 28441956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformity of package inserts information to regulatory requirements among selected branded and generic medicinal products circulating on the East African market.
    Sillo HB; Masota NE; Kisoma S; Rago L; Mgoyela V; Kaale EA
    PLoS One; 2018; 13(5):e0197490. PubMed ID: 29787579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of national essential medicines lists in the Americas.
    Steiner L; Maraj D; Woods H; Jarvis J; Yaphe H; Adekoya I; Bali A; Persaud N
    Rev Panam Salud Publica; 2020; 44():e5. PubMed ID: 31998375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of antibiotics included in national essential medicines lists of 138 countries using the WHO Access, Watch, Reserve (AWaRe) classification: a cross-sectional study.
    Adekoya I; Maraj D; Steiner L; Yaphe H; Moja L; Magrini N; Cooke G; Loeb M; Persaud N
    Lancet Infect Dis; 2021 Oct; 21(10):1429-1440. PubMed ID: 34332706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.